Christopher Christophi

12.9k total citations · 1 hit paper
198 papers, 5.7k citations indexed

About

Christopher Christophi is a scholar working on Surgery, Oncology and Hepatology. According to data from OpenAlex, Christopher Christophi has authored 198 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Surgery, 54 papers in Oncology and 48 papers in Hepatology. Recurrent topics in Christopher Christophi's work include Pancreatic and Hepatic Oncology Research (27 papers), Organ Transplantation Techniques and Outcomes (27 papers) and Hepatocellular Carcinoma Treatment and Prognosis (27 papers). Christopher Christophi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (27 papers), Organ Transplantation Techniques and Outcomes (27 papers) and Hepatocellular Carcinoma Treatment and Prognosis (27 papers). Christopher Christophi collaborates with scholars based in Australia, United States and Japan. Christopher Christophi's co-authors include Vijayaragavan Muralidharan, Mehrdad Nikfarjam, Christine M. Cuthbertson, Eleanor I Ager, Jaclyn Neo, Cathy Malcontenti‐Wilson, Jurstine Daruwalla, Caterina Malcontenti‐Wilson, Laurence Weinberg and Theodora Fifis and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Christopher Christophi

197 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Restrictive versus Liberal Fluid Therapy for Major Abdominal Surgery

2018 475 citations Paul S. Myles, Rinaldo Bellomo et al. profile →

Peers

Countries citing papers authored by Christopher Christophi

Since Specialization

Citations

This map shows the geographic impact of Christopher Christophi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Christophi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Christophi more than expected).

Fields of papers citing papers by Christopher Christophi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Christophi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Christophi. The network helps show where Christopher Christophi may publish in the future.

Co-authorship network of co-authors of Christopher Christophi

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Christophi. A scholar is included among the top collaborators of Christopher Christophi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Christophi. Christopher Christophi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated levels of circulating mitochondrial DNA predict early allograft dysfunction in patients following liver transplantation 2021 ·Journal of Gastroenterology and Hepatology ·Osamu Yoshino, (unknown), Daniel Cox, Eunice Lee, Graham Hepworth, Christopher Christophi, Robert M. Jones, Alexander Dobrovic, Vijayaragavan Muralidharan, Marcos V. Perini	15
2	The Hepatitis B Virus Pre-Core Protein p22 Activates Wnt Signaling 2020 ·Cancers ·(unknown), Dustin J. Flanagan, Gregor Ebert, Nadia Warner, Hoanh Tran, Theodora Fifis, (unknown), Christopher Christophi, Marc Pellegrini, Joseph Torresi, Toby J. Phesse, Elizabeth Vincan	15
3	Immunomodulatory effects of renin–angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases 2020 ·Journal for ImmunoTherapy of Cancer ·(unknown), Katrina A. Walsh, Theodora Fifis, Rita Paolini, (unknown), Christopher Christophi, Marcos V. Perini	25
4	Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Vijayaragavan Muralidharan, Niall C. Tebbutt, Pok Fai Wong, Chao Fang, (unknown), Hui Gan, John Sachinidis, Kunthi Pathmaraj, Christopher Christophi, Andrew M. Scott	4
5	The hospital costs of complications following colonic resection surgery: A retrospective cohort study 2020 ·Annals of Medicine and Surgery ·(unknown), (unknown), Leonid Churilov, Ronald Ma, (unknown), Adele Burgess, Christopher Christophi, Laurence Weinberg	12
6	Age 80 years and over is not associated with increased morbidity and mortality following pancreaticoduodenectomy 2017 ·ANZ Journal of Surgery ·(unknown), Michael Fink, Marcos V. Perini, (unknown), Laurence Weinberg, Vijayaragavan Muralidharan, Graham Starkey, Robert Jones, Christopher Christophi, Mehrdad Nikfarjam	20
7	Health economic implications of complications associated with pancreaticoduodenectomy at a University Hospital: a retrospective cohort cost study 2017 ·HPB ·(unknown), Ronald Ma, (unknown), Leonid Churilov, David Debono, (unknown), Mehrdad Nikfarjam, Christopher Christophi, Laurence Weinberg	21
8	Restrictive versus liberal fluid therapy in major abdominal surgery (RELIEF): rationale and design for a multicentre randomised trial 2017 ·BMJ Open ·Paul S. Myles, Rinaldo Bellomo, Tomás Corcoran, Andrew Forbes, Sophie Wallace, Philip J. Peyton, Christopher Christophi, David Story, Kate Leslie, Jonathan W. Serpell, Shay McGuinness, Rachael Parke	36
9	Donor-specific cell-free DNA as a non-invasive marker of organ rejection after liver transplantation: A pilot study 2016 ·Transplantation ·Su Kah Goh, Hongdo Do, (unknown), Alexander Dobrovic, Christopher Christophi	2
10	Steroid Sex Hormones, Sex Hormone–Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program 2015 ·The Journal of Clinical Endocrinology & Metabolism ·Kieren J. Mather, (unknown), Christopher Christophi, Vanita R. Aroda, William C. Knowler, (unknown), José C. Florez, Fernand Labrie, Steven E. Kahn, Ronald Goldberg, Elizabeth Barrett‐Connor	50
11	Blockade of the renin–angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver 2014 ·Clinical & Experimental Metastasis ·(unknown), Eleanor I Ager, Patricia Costa, Cathy Malcontenti‐Wilson, Vijayaragavan Muralidharan, Christopher Christophi	31
12	Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor 2013 ·QUT ePrints (Queensland University of Technology) ·Theodora Fifis, Linh T. Nguyen, Cathy Malcontenti‐Wilson, (unknown), (unknown), Jurstine Daruwalla, Mehrdad Nikfarjam, Vijayaragavan Muralidharan, Mark Waltham, Erik W. Thompson, Christopher Christophi	1
13	Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met 2013 ·Clinical & Experimental Metastasis ·Nadia Harun, Patricia Costa, Christopher Christophi	10
14	Prognostic Ability of ¹⁸F-FDG PET/CT in the Assessment of Colorectal Liver Metastases 2012 ·Journal of Nuclear Medicine ·Vijayaragavan Muralidharan, (unknown), Sze Ting Lee, Lawrence Lau, Andrew M. Scott, Christopher Christophi	30
15	Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation 2011 ·BMC Cancer ·Eleanor I Ager, Shu Wen, (unknown), (unknown), Jaclyn Neo, Christopher Christophi	15
16	Changes in the renin angiotensin system during the development of colorectal cancer liver metastases 2010 ·BMC Cancer ·Jaclyn Neo, Eleanor I Ager, Peter Angus, Jin Zhu, Chandana B. Herath, Christopher Christophi	77
17	Comparison of 980- and 1064-nm Wavelengths for Interstitial Laser Thermotherapy of the Liver 2005 ·Photomedicine and Laser Surgery ·Mehrdad Nikfarjam, Caterina Malcontenti‐Wilson, Christopher Christophi	9
18	Patterns of heat shock protein (HSP70) expression and Kupffer cell activity following thermal ablation of liver and colorectal liver metastases 2005 ·International Journal of Hyperthermia ·Mehrdad Nikfarjam, Vijayaragavan Muralidharan, (unknown), Cathy Malcontenti‐Wilson, Christopher Christophi	40
19	Interstitial laser thermotherapy in the treatment of colorectal liver metastases 2001 ·Journal of Surgical Oncology ·Vijayaragavan Muralidharan, Christopher Christophi	1
20	Accelerated tumour recurrence following percutaneous laser hyperthermia of colorectal liver metastases 2000 ·HPB ·Christopher Christophi, Vijayaragavan Muralidharan	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact